Kelowna General Hospital is a tertiary referral hospital located in Kelowna, British Columbia operated by Interior Health that offers medical care in the Central Okanagan.

There are 711 beds in Kelowna General Hospital.

During the past decade, Kelowna General Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 7 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kelowna General Hospital" #1 sponsor was "University of British Columbia" with 5 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Kelowna General Hospital" with 2 trials sponsored, "Sanofi" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kelowna General Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Genome British Columbia" with 2 trials as a collaborator, "University of British Columbia" with 2 trials as a collaborator, "University of Toronto" with 2 trials as a collaborator and "Boston VA Research Institute, Inc." with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Kelowna General Hospital" are "Stroke" (4 trials), "Pacemaker" (2 trials), "Pulmonary Embolism" (2 trials), "Acute Cerebral Ischemia" (1 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Kelowna General Hospital" in a lesser frequency.

Most popular intervention types in "Kelowna General Hospital" are "Drug" (12 trials), "Behavioral" (4 trials), "Other" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "(LMW)heparin" (1 trials), "ACT-064992 (macitentan)" (1 trials), "Acenocoumarol VKA" (1 trials) and "An inpatient homework based exercise program for the upper limb post stroke" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kelowna General Hospital" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Kelowna General Hospital". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Kelowna General Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kelowna General Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".